Pulle Mohan Venkatesh, Puri Harsh Vardhan, Asaf Belal Bin, Bishnoi Sukhram, Malik Manish, Kumar Arvind
Centre for Chest Surgery, Sir Ganga Ram Hospital, New Delhi, India.
Department of Nephrology, Sir Ganga Ram Hospital, New Delhi, India.
Korean J Thorac Cardiovasc Surg. 2020 Dec 5;53(6):392-399. doi: 10.5090/kjtcs.20.111.
Surgical treatment of empyema thoracis in patients with chronic kidney disease is challenging, and few studies in the literature have evaluated this issue. In this study, we aim to report the surgical outcomes of empyema and to analyze factors predicting perioperative mortality in patients with chronic kidney disease.
This retrospective study included data from 34 patients with chronic kidney disease (estimated glomerular filtration rate <60 mL/min/1.73 m2 for 3 or more months) who underwent surgery for empyema between 2012 and 2020. An analysis of demographic characteristics and perioperative variables, including complications, was carried out. Postoperative mortality was the primary outcome measure.
Patients' age ranged from 20 to 74 years with a 29-to-5 male-female ratio. The majority (n=19, 55.9%) of patients were in end-stage renal disease (ESRD) requiring maintenance hemodialysis. The mean operative time was 304 minutes and the mean intraoperative blood loss was 562 mL. Postoperative morbidity was observed in 70.5% of patients (n=24). In the subgroup analysis, higher values for operative time, blood loss, intensive care unit stay, and complications were found in ESRD patients. The mortality rate was 38.2% (n=13). In the univariate and multivariate analyses, poor performance status (Eastern Cooperative Oncology Group >2) (p=0.03), ESRD (p=0.02), and late referral (>8 weeks) (p<0.001) significantly affected mortality.
ESRD, late referral, and poor functional status were poor prognostic factors predicting postoperative mortality. The decision of surgery should be cautiously assessed given the very high risk of perioperative morbidity and mortality in these patients.
慢性肾脏病患者脓胸的外科治疗具有挑战性,文献中很少有研究评估这一问题。在本研究中,我们旨在报告脓胸的手术结果,并分析预测慢性肾脏病患者围手术期死亡率的因素。
这项回顾性研究纳入了2012年至2020年间34例因脓胸接受手术的慢性肾脏病患者(估计肾小球滤过率<60 mL/min/1.73 m²达3个月或更长时间)的数据。对人口统计学特征和围手术期变量(包括并发症)进行了分析。术后死亡率是主要结局指标。
患者年龄在20至74岁之间,男女比例为29比5。大多数患者(n = 19,55.9%)处于终末期肾病(ESRD),需要维持性血液透析。平均手术时间为304分钟,平均术中失血量为562 mL。70.5%的患者(n = 24)出现术后并发症。在亚组分析中,ESRD患者的手术时间、失血量、重症监护病房住院时间和并发症发生率更高。死亡率为38.2%(n = 13)。在单因素和多因素分析中,体能状态差(东部肿瘤协作组>2)(p = 0.03)、ESRD(p = 0.02)和延迟转诊(>8周)(p<0.001)显著影响死亡率。
ESRD、延迟转诊和功能状态差是预测术后死亡率的不良预后因素。鉴于这些患者围手术期发病率和死亡率非常高,应谨慎评估手术决策。